Company performance
Add to research
Current Price
as of Mar 14, 2025$97.16
P/E Ratio
77.91
Market Cap
$143.39B
Description
Add to research
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Metrics
Add to research
Overview
- HQMarlborough, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBSX
- Price$97.16+1.88%
Trading Information
- Market cap$143.39B
- Float99.53%
- Average Daily Volume (1m)8,756,380
- Average Daily Volume (3m)6,829,986
- EPS$1.26
Company
- Revenue$16.75B
- Rev growth (1yr)17.61%
- Net income$1.85B
- Gross margin61.31%
- EBITDA margin23.31%
- EBITDA$3.90B
- EV$143.66B
- EV/Revenue8.58
- P/E77.91
- P/S8.62
- P/B6.58
- Debt/Equity51.58
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset